KIORA PHARMACEUTICALS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -94.5% | -94.5% | -68.4% |
| FY2022 | -119.1% | -119.1% | -72.7% |
| FY2023 | -204.8% | -204.8% | -91.3% |
| FY2024 | 14.0% | 14.0% | 9.9% |
| FY2025 | -67.2% | -67.2% | -44.7% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -94.5% | -94.5% | -68.4% |
| FY2022 | -119.1% | -119.1% | -72.7% |
| FY2023 | -204.8% | -204.8% | -91.3% |
| FY2024 | 14.0% | 14.0% | 9.9% |
| FY2025 | -67.2% | -67.2% | -44.7% |